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ABSTRACT: In this study, interactions of polyethylene glycol
(PEG)-coated gold nanoparticles (AuNPs) with cells were
investigated with particular focus on the relationship between
the PEG layer properties (conformation, grafting density, and
hydrodynamic volume) and cell cycle arrest, apoptosis, and
DNA damage. Steric hindrance and PEG hydrodynamic
volume controlled the protein adsorption, whereas the
AuNP core size and PEG hydrodynamic volume were primary
factors for cell uptake and viability. At all PEG grafting
densities, the particles caused significant cell cycle arrest and
DNA damage against CaCo2 and PC3 cells without apoptosis. However, at a particular PEG grafting density (∼0.65 chains/
nm2), none of these severe damages were observed on 3T3 cells indicating discriminating behavior of the healthy (3T3) and
cancer (PC3 and CaCo2) cells. It was concluded that the PEG grafting density and hydrodynamic volume, tuned with the PEG
concentration and AuNP size, played an important role in particle−cell interactions.
■ INTRODUCTION
Gold nanoparticles (AuNPs) are promising tools for drug/gene
delivery,1−8 cellular imaging, cancer diagnostics and therapy,
and theranostic applications9−15 because of their unique
features such as biocompatibility, controllable sizes, easy
preparation/modification, and strong plasmonic proper-
ties.16−18 In most of the in vitro and in vivo studies, the
surface of the AuNPs is modified with polyethylene glycol
(PEG) to enhance colloidal stability in a physiological medium,
to improve biocompatibility,19−23 and to provide conjugation
sites for therapeutic agents and targeting ligands.4,5,8,11,24−28
The data in the literature demonstrate that the size, shape, and
surface modification of AuNPs significantly affect their cellular
uptake,29−37 intracellular localization,19,38−42 and toxic-
ity.19,31,33,37,43−48 Although numerous studies exist focusing
on the cell uptake and toxicity of AuNPs, the potential effects of
surface-modified or bare AuNPs on cell cycle steps, apoptosis,
and DNA damage have been investigated only in a few in vitro
studies.19,43,49−55 Most of these studies correlated the
interaction between the particles and cells in terms of surface
charge and PEG grafting density of particles. On the other
hand, the effect of the PEG hydrodynamic volume on the cell−
particle interactions was rarely considered.56−58
In this work, detailed characterization of PEG-modified
AuNPs is presented by investigating the effects of the core size
and PEG concentration on the size, surface charge, PEG layer
conformation, grafting density, and hydrodynamic volume. For
this purpose, two different AuNP core sizes, 5 and 13 nm, and
three different PEG coating concentrations, 0.2, 0.6, and 1 mg/
mL, were selected. The size of AuNPs is one of the key factors
determining the mode of elimination from the body, hence
dictating the in vivo biodistribution profile of the nanoparticles.
To prevent the accumulation of the nonbiodegradable AuNPs
in the body, the size of the nanoparticles must enable their
renal clearance because this mode of elimination implies no
degradation of the nanoparticle. The studies in the literature
indicated that gold particles larger than 10 nm will inevitably be
captured by the liver (or other organs of the reticuloendothelial
system) after opsonization regardless of their surface properties,
whereas a hydrodynamic diameter of less than 10 nm leads to
renal elimination.59−62 Considering this fact, this study is
planned based on two AuNP core sizes below and above the
suggested size limit (10 nm). The influence of the PEG grafting
density and hydrodynamic volume on the stability (protein
adsorption), cell uptake, toxicity, cell cycle phases, apoptosis,
and DNA damage were evaluated against prostate (PC3) and
colon (CaCo2) cancer cell lines and healthy 3T3 fibroblast
cells. These common cell types were selected because of their
distinct properties and widespread use as model cancer or
control cell lines in cancer nanomedicine research.63−66 To the
best of our knowledge, the interaction between the PEGylated
AuNPs and these cell lines has not been investigated previously.
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■ MATERIALS AND METHODS
Chemicals and Materials. Hydrogen tetrachloroaurate(III)
trihydrate (99.9%), sodium citrate, and sodium borohydrate used in
the preparation of AuNPs were purchased from Sigma-Aldrich. Thiol
and amine end-group-modified PEG (SH−PEG−NH2: MW 1000)
used for the surface modification of nanoparticles was purchased from
Creative PEG works. The fluorescence dyes, 4′,6-diamidino-2-
phenylindole (DAPI) and fluorescein isothiocyanate (FITC), used in
staining cells and PEG-coated AuNPs, respectively, were from Sigma-
Aldrich. The colon cancer cell line, CaCo2 (ATCC HTB-37), prostate
cancer cell line, PC-3 (ATCC CRL-1435), and 3T3 fibroblast (ATCC
CRL-1658) were obtained from American Type Culture Collection.
The cell culture media, Dulbecco’s Modified Eagle Medium (DMEM)
and RPMI Medium 1640, and cell culture medium additives, fetal
bovine serum (FBS) and penicillin streptomycin, were obtained from
Invitrogen. An annexin V staining kit for apoptosis detection,
propidium iodide (PI) dye, and 3-(4,5-dimethythiazol-2-yl)-2,5-
diphenyl tetrazolium bromide (MTT) toxicity assay dye were obtained
from Sigma-Aldrich.
Preparation of AuNPs and PEG Modification. The 5 and 13
nm AuNPs were prepared using classical sodium borohydrate and
sodium citrate reduction, respectively.67,68 To modify the surface, the
SH−PEG−NH2 was added to 10 nM nanoparticle solutions. The PEG
concentration in the reaction medium was 0.2, 0.6, or 1 mg/mL. The
reaction was carried out at room temperature in the dark under
nitrogen with continuous stirring for 24 h. At the end of the reaction,
the resultant nanoparticles were centrifuged at 15 000 rpm for 20 min
and washed with phosphate buffer (PBS) four times to eliminate
weakly bound PEGs. The attached PEG amount was calculated as
described in Figure S2 and Table S1 in accordance with the protocol
published in the literature.20,69,70 For fluorescence microscopy
imaging, the PEG-coated AuNPs were reacted with FITC dye.19,38
For this reaction, 1 mg of FITC was dissolved in 200 μL of anhydrous
dimethylformamide (DMF) and added to 50 μM PEG-coated AuNP
solution. The suspension was vortexed and placed on a shaker for 24 h.
Free FITC molecules were removed by centrifugation and washing
with PBS containing 15% DMF. Complete removal of free FITC
molecules was verified by monitoring the fluorescence of the
supernatant using a fluorescence spectrophotometer.
Characterization of the Bare and PEG-Coated AuNPs. The
size, size distribution, and zeta potential of the particles were
determined by dynamic light scattering (DLS) (Malvern Zetasizer
Nanozs90). A UV−vis spectrophotometer (Perkin Elmer Lambda45)
was used to determine the change in the spectra of the particles caused
by surface modification. To evaluate the stabilities of the particles, they
were incubated in a serum-supplied cell culture medium at 37 °C in a
5% CO2-humidified atmosphere. Following incubation, the samples
were centrifuged and washed with PBS to remove the medium. Then,
the size and zeta potential of the particles resuspended in PBS were
measured with DLS.
The naked AuNPs and AuNP−PEG particles were visualized by
transmission electron microscopy (TEM) (FEI-Tecnai 2-F20). After
the removal of free PEG on the surface of the particles through
centrifugation and further washing with PBS, the samples were
prepared by dipping a carbon-coated copper grid (Ted Pella 400 mesh
Cu Holey Carbon) in 20 μL of colloidal nanoparticle solution and air
dried before taking images. For visualization of the PEG layer around
AuNPs, a copper grid, prepared as described above, was immersed in a
uranyl acetate (2% v/v) aqueous solution for 5 min. Excess solution on
the grid was wiped off using a filter paper, and residual solution was air
dried. X-ray photoelectron spectroscopy (XPS) was also used to
confirm the presence of the PEG layer on AuNPs. Samples were
prepared by adding a small drop of an aqueous solution of AuNPs
onto a silicon wafer and air dried. Analyses were performed using a
monochromatic Al Kα X-ray source (1486.6 eV) with an Omni Focus
III small-area lens and a multichannel detector. Measurements were
taken at an electron take-off angle 45° from a normal sampling surface
depth of ∼50 Å. The binding energy scale was calibrated prior to
analysis by the Au4f7/2 peak at 83.9 eV. Survey scans were collected
from 10 to 1100 eV with a pass energy of 187.85 eV. All spectra were
referenced by setting the C 1s peak to 285.0 eV to compensate for
residual charging effects.
Cell Culture. PC3 cells and 3T3 cells were cultured in high glucose
DMEM supplemented with 10% FBS, whereas the CaCo2 cell line was
cultured in RPMI medium supplemented with 10% FBS. Cell cultures
were kept at 37 °C in a 5% CO2-humidified incubator and subcultured
two times per week.
Cellular Uptake by Inductively Coupled Plasma Mass
Spectroscopy (ICP-MS). To measure the time-dependent cellular
uptake and cellular accumulation of AuNP−PEG particles, PC3,
CaCo2, and 3T3 cells (2 × 105 cell/well) were plated in each well and
incubated with the PEG-coated AuNPs at 37 °C in a 5% CO2-
humidified incubator for 24 h. After incubation, the cell culture
medium was removed, and the exposed cells were further washed with
PBS to remove nanoparticles existing in the medium or adhering to
the outer cell membrane. The cells were then harvested, dispersed into
the culture medium, and collected by centrifugation. After the removal
of the supernatant, the cell pellet was treated with 500 μL of
concentrated nitric acid (HNO3) at 70 °C for 4 h to digest AuNPs.
19
The quantity of Au was analyzed by ICP-MS (Agilent 7500ce) and the
number of AuNPs per cell was calculated as shown in the Supporting
Information.
MTT Assay. The PC3, CaCo2, and 3T3 cells (95 μL) were plated
at a density of 1 × 104 cells/well in 96-well plates. After 24 h
incubation at 37 °C in a 5% CO2-humidified incubator, the cells were
exposed to different concentrations of 5 and 13 nm AuNPs (5 μL)
(12.5, 25, and 50 μM) coated by different PEG concentrations (0.2,
0.6, and 1 mg/mL) and incubated for 24 h. Following incubation, the
cell culture medium in the well plates was removed, and 100 μL of
MTT dye (0.5 mg/mL in PBS at pH 7.4) was added to each well and
incubated for further 4 h. At the end of incubation, the 96-well plate
was centrifuged, and the medium was removed. Then, the precipitated
formazan crystals were solubilized with 100 μL of DMSO, and the
absorbance was measured spectrophotometrically at 570 nm in a
microplate reader (Thermo Scientific, Varioskan Multimode Micro-
plate Reader).
Cell Cycle and Apoptosis Analysis with Flow Cytometry.
PC3, CaCo2, and 3T3 cells were grown (2 × 105 cell/well) in 6-well
plates at 37 °C in a 5% CO2-humidified incubator for 24 h and then
further incubated under the same conditions with AuNP−PEG
particles (12.5, 25, and 50 μM) in the culture medium for another
24 h. After incubation, cells were harvested and centrifuged at 1200
rpm for 10 min, and the supernatant was discarded. The precipitated
cells were suspended in 1 mL of PBS solution, fixed with cold ethanol
(at −20 °C, 70%) under continuous vortexing, and stored at −20 °C
until analysis. On the day of the experiment, the fixed cell suspensions
were washed by centrifugation (1200 rpm for 10 min) three times, and
the precipitate was suspended in 1 mL of PBS containing 0.1% Triton
X-100. The cells were further treated with 200 μg/mL RNase for 30
min at 37 °C, and then, DNA staining with 100 μg/mL propidium
iodine was conducted at room temperature for 15 min. Samples were
analyzed through a flow cytometer (BD Biosciences Facs Canto), and
data were analyzed using Modfit flow cytometry analyzing software.
For the apoptosis test, the same AuNP−PEG particles at the same
doses were applied to the cells and incubated as in cell cycle analysis.
The cells were then harvested, washed with cold PBS, and centrifuged.
The cell pellet was resuspended in annexin-binding buffer, and 5 μL of
annexin V FITC conjugate and PI solution were sequentially added to
the sample to detect apoptotic and necrotic cell populations,
respectively. Finally, the cells were incubated at room temperature
for 15 min, and measurements were conducted by using a flow
cytometer.
Comet Assay. The cells grown in 6-well plates (2 × 105 cell/well)
were exposed to PEGylated AuNPs for 24 h at 37 °C in a 5% CO2-
humidified incubator. Then, they were harvested, washed with PBS
twice, and resuspended in PBS. The cell suspension (5 μL) was
embedded in 75 μL of 1% low-melting agarose and spread on
previously prepared comet slides and lysed in prechilled lysis solution
[1.2 M NaCl, 100 mM Na2EDTA, 0.1% sodium lauryl sarcosinate, and
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0.26 M NaOH (pH > 13)] for 24 h. Cells were then treated with a
denaturation solution [0.03 M NaOH, 2 mM Na2EDTA (pH 12.3)]
for 45 min in the dark at room temperature. Following denaturation,
electrophoresis was performed at 25 V and 90 mA for 20 min. The
slides were immersed in dH2O for neutralization for 15 min.
Subsequently, they were stained with PI dye (10 μg/mL) for 20
min and washed with water to remove excess dye.71 Hydrogen
peroxide (H2O2) was used as the positive control. The images were
taken by using fluorescence microscopy and analyzed using image
analysis software.
Fluorescence Microscopy. PC3, CaCo2, and 3T3 cells (2 × 105
cell/well) were plated in each well and grown on a microscope slide at
37 °C in a 5% CO2-humidified incubator for 24 h. The cells were
further incubated with the FITC-attached PEG-coated AuNPs for 24 h
under the same conditions. After incubation, the cell culture medium
was removed, and the exposed cells were further washed with PBS.
The cells were then fixed with 4% paraformaldehyde (PFA) in PBS for
20 min at room temperature, washed with PBS three times, and
permeabilized with 1 mL of 0.1% Triton X-100 in PBS for 15 min at
room temperature. Following this, the cells were blocked with 0.5 mL
of 3% BSA in 0.1% Triton X-100/PBS for 30 min. Finally, the cells
were incubated with 100 μL of DAPI dye for 5 min in the dark. At the
end of incubation, the cells were washed with PBS and mounted with
1:1 PBS/glycerol on a microscope slide before taking fluorescence
images.
Statistical Analysis. The significant difference between the groups
was evaluated by ANOVA analysis by Tukey’s method with a 95%
confidence interval. The results were presented as mean, and standard
deviations were calculated from at least three independent experiments
with three repeats.
■ RESULTS AND DISCUSSION
Characterization of PEG-Modified AuNPs. Two different
sized (∼5 and ∼13 nm) bare AuNPs were synthesized and
modified with varying amounts of heterobifunctional PEG
(SH−PEG−NH2: 0.2, 0.6, and 1 mg/mL) to prepare PEG-
coated AuNPs with different sizes and surface properties. The
code of the nanoparticles along with the preparation conditions
are shown in Scheme 1.
The PEG layer coated on the AuNPs is observed in TEM
images shown in Figure 1 and its thickness is calculated from
DLS data (size distributions of particles are shown in Figure
S3). The TEM images clearly revealed the presence of the PEG
layer around AuNPs. The results in Table 1 have shown that
when the PEG concentration in the feed is increased, the
thickness of the PEG layer on both 5 and 13 nm sized
nanoparticles increases significantly (p < 0.05) (from 7.59 to
9.85 nm for 5 nm AuNPs and from 5.16 to 7.04 nm for 13 nm
AuNPs).23,69
The change in zeta potential values was another indication of
successful PEG coating. Upon PEG attachment, the negatively
charged surfaces of the bare AuNPs became positively charged
because of the presence of −NH2 groups at the open end of the
PEG (Table 1). The PEG concentration caused a slight
increase in the zeta potential of the conjugates formed from 5
nm AuNPs, whereas the zeta potential of the 13 nm sized
nanoparticles increased significantly by increasing the PEG
concentration from 0.2 to 1 mg/mL. The XPS data and the
UV−vis spectra of the nanoparticles also confirmed the success
of surface modification (Figures S4−S7). The stabilities of the
particles in the serum-supplemented cell culture medium were
evaluated through the changes in the size and zeta potential
values (Table 1). The bare AuNPs showed a significant
agglomeration tendency. Their sizes increased, whereas their
zeta potential values decreased because of the attachment of
cell culture medium components. In general, the PEG-coated
AuNPs, except particles B and C (Table 1), were stable in the
medium as confirmed by no significant change in their sizes
after incubation with the medium.
The conformation of PEG chains attached to the nano-
particles was calculated from the Flory radius (RF). As shown in
eq 1, the Flory radius is a function of the PEG size (a = 3.5 Å)
and the number of monomer units (N).69,72
=R aNF 3/5 (1)
The PEG chains can acquire either ‘mushroom’ or ‘brush’
configurations. The mushroom conformation mainly occurs
when the distance, D, between the attachment points of PEG to
the surface is larger than RF (D > RF); however, the brush
conformation is observed when D < RF.
49,69
Using the thickness of the PEG layer obtained from DLS
measurements (t) and the density of PEG (ρ = 1.09 g/mL), the
surface concentration (Γ, g/nm2) and the average distance
between grafted PEG chains (D, nm) were calculated using eqs
2 and 3, respectively.
ρΓ = t (2)
=
Γ
⎛
⎝⎜
⎞
⎠⎟D
M
NA
1/2
(3)
σ = ⎜ ⎟⎛⎝
⎞
⎠
a
D
2
(4)
In eqs 3 and 4, M is the PEG molecular weight (Da), NA is
Avogadro’s number (6.02 × 1023 mol−1), and σ is the grafting
density. The hydrodynamic volume of the single PEG molecule
attached on the AuNP surface was calculated by dividing the
total hydrodynamic volume of the PEG layer formed on AuNPs
by the total number of PEG molecules per nanoparticle. The
conformation, PEG grafting densities, and PEG hydrodynamic
volumes of the particles determined from the above given
calculations are summarized in Table 1.
Theoretical calculations indicated that the PEG layers
deposited on each particle possessed brush-like conformation
(Table 1). This finding suggested that a sufficient amount of
PEG was indeed utilized for the modification of particles
leading to the PEG chains to adopt a brush-like conformation
rather than a mushroom-like conformation.23,69,72,73 The PEG
grafting density on the particles increased with the increased
PEG concentration (Table 1). PEGylation on 5 nm sized
AuNPs yielded a higher grafting density than that on the 13 nm
Scheme 1. Description of PEG-Coated AuNPs
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sized ones because of the higher surface area and curvature of
small nanoparticles (size of 5 nm) allowing more PEG
attachment than the big ones (size of 13 nm), which is in
agreement with the findings in the literature.23,69 Experimental
quantification also indicated a higher PEG amount conjugated
onto 5 nm sized AuNPs (Figure S2 and Table S1). For the
particles prepared from the same core, as the PEG grafting
density increased, the hydrodynamic volume decreased because
of the compression of neighboring PEG molecules. On the
other hand, both the PEG grafting density and PEG
hydrodynamic volume decreased with the increased core size
(5 vs 13 nm). PEG chains on 5 nm particles adopt larger
hydrodynamic volumes compared with those on 13 nm
particles. This was attributed to the higher surface curvature
of smaller nanoparticles, reducing steric hindrance between
neighboring PEG molecules.23 Moreover, our results showed
that under equal PEG density, the PEG hydrodynamic volume
controlled the surface charge (Table 1). Particles A and B and
Figure 1. TEM images of bare and PEG-coated AuNPs. AuNP size: 5 and 13 nm. Applied PEG concentration: 0.2, 0.6, and 1 mg/mL.
Table 1. Intensity-Averaged Sizes and Zeta Potential Values of Prepared Particles before and after Serum-Supplemented Cell
Culture Medium Incubation, Conformation, PEG Layer Thickness, Grafting Density, and Hydrodynamic Volume of AuNP−
PEG Particlesa
before serum incubation after serum incubation
5 nm bare
AuNP particle A particle B particle C
5 nm bare
AuNP particle A particle B particle C
size (nm) 5.5 ± 1.2 13.09 ± 0.35 14.87 ± 0.62a 15.35 ± 1.34a 140.3 ± 5.97 13.5 ± 0.24 21.04 ± 0.36c 20.9 ± 1.34c
zeta potential (mV) −34.4 ± 0.9 11.2 ± 0.28 15.6 ± 1.03 12.6 ± 1.03 −12.6 ± 0.06 −7.7 ± 0.24 −20.8 ± 1.63d −21.5 ± 1.15d
PEG layer thickness (nm) 7.59 ± 0.24 9.37 ± 0.62 9.85 ± 1.34
grafting density
(no. of chains/nm2)
0.67 ± 0.02 0.75 ± 0.05 0.92 ± 0.1
PEG hydrodynamic
volumeVPEG (nm
3)
17.79 ± 0.52 16.72 ± 1.09 15.48 ± 1.36
conformation brush (RF > D)
before serum incubation after serum incubation
13 nm bare
AuNP particle D particle E particle F
13 nm bare
AuNP particle D particle E particle F
size (nm) 11.78 ± 1.34 16.94 ± 0.26 18.37 ± 0.99b 18.83 ± 0.07b 340 ± 17.7 16.39 ± 0.59 18.93 ± 0.58e 19.5 ± 1.5e
zeta potential (mV) −32.5 ± 1.67 16.1 ± 0.67 19.6 ± 0.32 21.6 ± 0.23 −26.5 ± 0.64 −10 ± 0.19 −21.2 ± 1.66f −21.1 ± 1.3f
PEG layer thickness (nm) 5.16 ± 0.26 6.59 ± 0.85 7.04 ± 0.07
grafting density
(no. of chains/nm2)
0.36 ± 0.05 0.53 ± 0.08 0.62 ± 0.12
PEG hydrodynamic
volumeVPEG (nm
3)
11.05 ± 1.12 10.47 ± 1.58 9.11 ± 0.58
conformation brush (RF > D)
aThe same letters represent a statistically insignificant difference (p > 0.05).
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particles E and F have similar PEG grafting densities; however,
the zeta potential of particles A and B was found to be lower.
The hydrodynamic volume occupied by PEG molecules is
larger on particles A and B. As a result, the positively charged
−NH2 end groups on the PEG chains are partly embedded in
the voids of the PEG layer on the surface, decreasing the zeta
potential value. It should also be noted that an increased PEG
grafting density leads to higher zeta potential values because of
the presence of more positively charged amine groups on the
surface of the particles.
We qualitatively evaluated the serum protein adsorption
levels from the changes in the zeta potential values upon
incubating the nanoparticles with the serum containing cell
culture media. For the particles with similar sizes prepared from
Figure 2. Time-dependent cellular uptake of PEG-modified AuNPs in (A) CaCo2 cells, (B) PC3 Cells (C) 3T3 Cells. Applied dose: 50 μM.
Incubation times: 15, 30, and 60 min and 24 h. The values reported at the end of 24 h incubation represent the cellular accumulation of the particles.
The cellular accumulation of 5 nm bare AuNPs at the end of 24 h incubation was 0.16 × 106 ± 0.03 for CaCo2, 0.86 × 106 ± 0.04 for PC3, and 0.21
× 106 ± 0.00 for 3T3 cells. The cellular accumulation of 13 nm bare AuNPs at the end of 24 h incubation was 0.02 × 106 ± 0.00 for CaCo2, 0.05 ×
106 ± 0.00 for PC3, and 0.02 × 106 ± 0.00 for 3T3 cells. The same letters indicate the statistical indifference: a−c (p > 0.05). * indicates the
statistical difference for all cases: *p < 0.05.
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the same core (particles A−C or particles D−F), the protein
adsorption level increased with the increased zeta potential
(Table 1). It is expected that the zeta potential value increases
with the increased grafting density of amine-terminated PEG
molecules leading to higher protein adsorption. In the case of
particles with similar sizes prepared from different cores
(particles C vs particle D), the protein adsorption level
decreased with the decrease in the PEG hydrodynamic volume.
Although particle D has a higher zeta potential value than
particle C, lower protein adsorption on particle D suggested
that the hydrodynamic volume plays a more dominant role in
the protein adsorption rather than the PEG grafting density,
hence resulting in the difference in the zeta potential. The
dominance of the hydrodynamic volume disappears when the
zeta potential of the particles are significantly different. The
protein adsorption resulted in an increase in the sizes of
particles B and C as compared with that of particle A (Table 1).
This might be because of the presence of the higher density of
positively charged −NH2 groups on the surfaces of particles B
and C, enhancing the possibility of negatively charged cell
culture media components, such as albumin with an average
hydrodynamic diameter of ∼7 nm,74−76 to be attached to the
surface. On the other hand, the lower grafting density and
higher hydrodynamic volume of PEG on particle A possibly
allows proteins to penetrate and embed into the PEG layer
Figure 3. Cell viability of CaCo2 cells exposed to AuNP−PEG particles. Incubation time: 24 h. a−h represent doses of particles which caused
significant difference in cell viability. i represents PEG coating concentration that caused a significant difference in cell viability for particles A and C
at a dose of 50 μM. j and k represent PEG coating concentration that caused a significant difference in cell viability for particle A and particles B and
C at a dose of 25 μM. l represents PEG coating concentration that caused a significant difference in cell viability for particles A and B at a dose of
12.5 μM. m and n represent PEG coating concentration that caused a significant difference in cell viability for particle D and particles E and F at a
dose of 50 μM, respectively. o and p represent PEG coating concentration that caused a significant difference in cell viability for particles D and E
and particles E and F at a dose of 25 μM. r and s represent the significant difference in the effect of the bare AuNP size on cell viability for particles C
and F at a dose of 50 μM and particles B and E at a dose of 25 μM, respectively. * represents the statistically significant effect of particles with respect
to control cells (p < 0.05).
Figure 4. Cell viability of PC3 cells exposed to AuNP−PEG particles. Incubation time: 24 h. a−d represent doses of particles that caused a significant
difference in cell viability. e represents PEG coating concentration that caused a significant difference in cell viability for particles A−C at 50 μM
dose. f and g represent the significant difference in the effect of PEG concentration on cell viability for particle A and particles B and C at 25 μM
dose. h and i represent PEG coating concentration that caused a significant difference in cell viability for particles A and C and particles B and C at
12.5 μM dose, respectively. j represents PEG coating concentration that caused significant difference in cell viability for particles D−F at 50 μM dose.
k and l represent the significant difference in the effect of PEG concentration on cell viability for particle D and particles E and F at 25 μM dose. m
and n represent the significant difference in the effect of PEG concentration on cell viability for particle D and particles E and F at 12.5 μM dose. o,
p, and r represent the effect of the bare AuNP size that caused a significant difference in cell viability for particles A and D at all doses. s and t
represent the significant difference in the effect of the bare AuNP size on cell viability for particles B and E and particles C and F at 50 μM dose. u
and v represent the significant difference in the effect of the bare AuNP size on cell viability for particles C and F at 25 and 12.5 μM doses,
respectively. * represents the statistically significant effect of particles with respect to control cells (p < 0.05).
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causing an insignificant size increase. The same applies to
particles D−F, which have lower PEG grafting densities.
Cellular Uptake and Cytotoxicity of PEG-Modified
AuNPs. Time-dependent uptake and accumulation of particles
by CaCo2, PC3, and 3T3 cells is investigated by measuring the
Au amount internalized by cells using ICP-MS. After 24 h
incubation of particles with cells, the amount of bare AuNPs in
all cell types was considerably lower than that of PEG-modified
particles because of a huge size increase of bare AuNPs resulted
from excessive agglomeration in serum containing cell culture
media (Figure 2). This indicates the advantage of PEGylation
on colloidal stability of AuNPs in serum containing media
enhancing their cellular uptake and accumulation. It was also
observed that the accumulation of the same particles
significantly varies depending on the cell line because of
different cellular characteristics.55,63 Figure 2 illustrates that the
uptake and cellular accumulation of particle C (and particle B)
are higher than those of particle F. Although their sizes and zeta
potential values after serum incubation are the same (Table 1),
this result suggests that the core size, PEG grafting density,
and/or hydrodynamic volume may control the cellular uptake.
In the case of particles A and F having the same grafting
densities, the higher uptake and accumulation of particle A than
those of particle F led to the conclusion that the dominant
factor on the uptake is either the PEG hydrodynamic volume or
the core size rather than the PEG grafting density of the
particles. This conclusion has indeed been confirmed by the
observation that particles D−F or particles A−C were taken up
by the cells at nearly the same rates although they have a
different surface charge, size, and grafting density but similar
PEG hydrodynamic volumes and the same core size.
The toxicities of the nanoparticles were found to be dose
dependent as illustrated in Figures 3−5. The increase in the
applied dose resulted in a decrease in the viability of all cell
lines with LD50 > 50 μg/mL. In general, the particles did not
show severe toxic effects on CaCo2 and 3T3 cell lines,
especially at low doses (12.5 and 25 μM), whereas their toxic
impact on PC3 cells were more severe (Figure 4) even in the
lowest applied dose for particle D. Although the accumulation
of particles A and C was at least 10-fold higher than that of
particles D and F, their effects on the cell viability were similar
or less. This result is in accordance with cellular uptake results.
Figure 5. Cell viability of 3T3 cells exposed to AuNP−PEG particles. Incubation time: 24 h. a−e represent doses of particles that caused a significant
difference in cell viability. f and g represent PEG coating concentration that caused a significant difference in cell viability for particles A and B at a
dose of 50 μM and particles A and C at a dose of 12.5 μM, respectively. h−j represent the significant difference in the effect of PEG concentration on
cell viability for particles D−F at all doses. k−m represent the effect of the bare AuNP size that caused a significant difference in cell viability for all
doses of particles A and D. n represents the significant difference in the effect of the bare AuNP size on cell viability for particles C and F at a dose of
50 μM. * represents the statistically significant effect of particles with respect to control cells except particle A at a dose of 12.5 μM (p < 0.05).
Figure 6. Complete cell cycle analysis of AuNP−PEG particle-exposed (50 μM) CaCo2 cells. Incubation time: 24 h. a−d represent the significant
difference in the G1 phase of cell cycle caused by the effect of PEG concentration and e and f represent the significant effect of the AuNP core size
on the G1 phase. g and h represent the significant difference caused by PEG concentration in the S phase of cell cycle, whereas i−k represent the
effect of the AuNP core size significantly altering the S phase. l represents the significant difference in the G2 phase of cell cycle caused by the effect
of PEG concentration, whereas m represents the significant difference in the G2 phase of cell cycle caused by the AuNP core size. *, **, and ***
represent the significant difference of AuNP−PEG particles with respect to control groups for G1, S, and G2 phases, respectively, (p < 0.05).
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It shows that the core size and/or PEG hydrodynamic volume
are the primary factors for the cell viability rather than the PEG
grafting density, surface charge, and particle size after serum
incubation. Among the cell lines tested, PC3 was the most
significantly influenced by the nanoparticles, whereas the same
particles caused different levels of toxicity on the cell types
because of different characteristics of the cells or intracellular
fate of the particles.55,63
Effect of PEG-Modified AuNPs on Cell Cycle,
Apoptosis, and DNA Damage. Literature studies have
demonstrated that the nanoparticles, which do not show any
toxic effect according to the classical toxicity test results, may
severely disrupt cell cycle steps and cause DNA damage or
apoptosis.54 Therefore, besides the classical toxicity tests, it is
also important to further investigate the effect of the particles
on cell cycle steps. Cell cycle is basically the mechanism
responsible for cell division and replication. It consists of four
subsequently connected phases (G1, S, G2, and M) where the
activation of each phase depends on the proper completion of
the previous one. A regular cell cycle starts with the G1 phase in
which cells prepare themselves for growth by increasing their
sizes. Following the G1 phase, the cells synthesize DNA during
the S phase. Finally, during the G2/M phase, cells synthesize
proteins required for cell division and cell division occurs
resulting in the formation of two daughter cells.77,78 In this
study, the effect of particles on cell cycle is investigated through
flow cytometry measurements. The changes in the G1, S, and
G2 phases for all cells treated with the particles are shown in
Figures 6−8 (for the histograms of cell cycle see Figures S8−
S10).
The results indicated that all of the particles caused severe
alteration in all cell cycle steps for both cancer cell lines, CaCo2
and PC3, although their cellular accumulation significantly
varied. In the case of the healthy fibroblast cell line, 3T3,
particles A and F (0.67−0.62 chains/nm2) with the same
grafting densities did not cause a significant cell cycle arrest
even though they displayed different cellular accumulation
(Figure 2). On the other hand, particles C and D possessing the
highest (0.92 chains/nm2) and the lowest (0.36 chains/nm2)
grafting densities increased the S phase and decreased the G2
phase arrest in 3T3 cells. It seems that an optimum PEG
grafting density (∼0.65 chains/nm2) existed at which particles
Figure 7. Complete cell cycle analysis of AuNP−PEG particle-exposed (50 μM) PC3 cells. Incubation time: 24 h. a and b represent the significant
difference in the G1 phase of cell cycle caused by the effect of PEG concentration, and c represents the significant effect of size. d−g represent the
significant difference caused by PEG concentration in the S phase of cell cycle, whereas h and i represent the effect of the AuNP core size
significantly altering the S phase. j represents the significant difference in the G2 phase of cell cycle caused by the effect of PEG concentration,
whereas k represents the significant difference due to the effect of AuNP core size. *, **, and *** represent the significant difference of AuNP−PEG
particles with respect to control groups for G1, S, and G2 phases, respectively, (p < 0.05).
Figure 8. Complete cell cycle analysis of AuNP−PEG particle-exposed (50 μM) 3T3 cells. Incubation time: 24 h. a represents the significant
difference in the G1 phase of cell cycle caused by the effect of PEG concentration, and b represents the significant effect of the AuNP core size. c−e
represent the significant difference caused by PEG concentration in the S phase of cell cycle, whereas f−h represent the effect of the AuNP core size
significantly altering the S phase. i−l represent the significant difference in the G2 phase of cell cycle caused by the effect of PEG concentration,
whereas m and n represent the significant difference due to the effect of the AuNP core size. o, p, and r represent the significant differences caused by
the particles with respect to control cases in G1, S, and G2 phases, respectively, (p < 0.05).
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did not severely alter the cell cycle phases for 3T3 cells. Thus, it
may be possible to minimize the alteration in cell cycle upon
exposure to AuNPs by changing the PEG grafting density. No
direct correlation was found between the toxicity and cell cycle
results. For instance, particles A and C showed different cell
viabilities (particle A: ∼60% and particle C: ∼80%) against PC3
cells (Figure 4); however, the disruption of cell cycle phases
caused by each particle was not significantly different (Figure
7). Particles C and D did not show severe toxicity (∼80% cell
viability) on 3T3 cells (Figure 5), yet they resulted in a
significant S phase arrest (Figure 8). Similarly, the severe cell
cycle phase arrest in nontoxic doses of applied nanoparticles
was also reported in the literature.54
The cells can be arrested at cell cycle checkpoints
temporarily to repair cellular damage, to dissipate an exogenous
cellular stress signal, or to provide essential growth factors,
hormones, or nutrients. Besides, in case the cellular damage is
too severe to be repaired, the activation of pathways leading to
apoptosis (programmed cell death) occurs through checkpoint
signaling.77 Although the particles caused significant cell cycle
phase arrests, they did not depict an apoptotic effect against the
cells (Figure 9). In addition, it was also observed that none of
the cells showed apoptotic behavior upon incubation with
particles during 48 and 72 h (Figure S11). This result implies
that the particles regardless of their physicochemical and
surface properties acted through pathways other than apoptosis
to inhibit cell growth or that they caused retarded cell
proliferation without accompanied massive apoptosis.55
Previous studies have shown that cells are arrested at
different phases of cell cycle or triggered apoptosis mechanisms
because of DNA damage caused by external or internal
effects.77−79 Basically, DNA damage triggers a signaling
network that induces phosphorylation and consequent
activation of ATM (Ataxia telangiectasia mutated), which
functions in DNA repair, apoptotic death, and cell cycle
arrest.54,78,79 We investigated possible DNA damage caused by
the PEG-coated AuNP particles using comet assay, which
detects single- and double-strand DNA breaks at individual
cells. Cells that have broken DNA fragments or damaged DNA
migrate much further and appear as fluorescent comets with
tails of DNA fragmentation, whereas undamaged DNA moves
minimally because of its large size.54 Our comet assay results
indicated that all particles caused DNA damage for cancer cells.
This suggests that PEGylated AuNPs reach the nucleus where
most of the DNA related events take place.
The results in Figure 10 indicated that for CaCo2 and PC3
cell lines, all particles caused significant DNA damage almost at
the same level. In the case of 3T3 cells, particles A and F with
the same PEG grafting densities (∼0.67 and 0.62 chains/nm2)
did not induce any DNA damage, whereas particles C and D
(with PEG grafting densities of 0.92 and 0.36 chains/nm2)
showed a severe DNA damage. This result is in accordance with
Figure 9. Apoptosis analysis of AuNP−PEG particle-exposed (50 μM) CaCo2, PC3, and 3T3 cells using flow cytometry. Incubation time: 24 h.
Figure 10. Tail moments of the cells exposed to AuNP−PEG particles (50 μM). Incubation time: 24 h. *, **, and *** represent the significant
difference of AuNP−PEG particles with respect to control groups (p < 0.05).
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the cell cycle alterations of 3T3 cells illustrated in Figure 8.
From the results, it appeared that an optimum PEG grafting
density also existed for the effect of particles on DNA integrity.
It is known that the same particles possessing the same
chemical and physical properties affected cancer and normal
cell lines differently because of differences in their interactions
with cells. Kang et al., (2010) have proved that 0.4 nM
concentration of AuNPs targeting the nucleus of cancer cells
caused disruption of cytokinesis inhibiting these cells from
completing cell division, triggering DNA damage, and following
apoptosis; however, none of these effects were observed in any
normal cell groups treated by the same amount and type of
AuNP.52 In our study, particles with a grafting density of ∼0.65
did not cause any cell cycle arrest and DNA damage in 3T3
cells, whereas the particles with grafting density below and
above this value (∼0.65) caused significant cell cycle alteration
and DNA damage. This is thought to be because of the
different surface properties of the particles. It is expected for the
particles to have relatively different hydrophobic surfaces
because of their different PEG grafting densities, hydrodynamic
volumes, and also conformations, which results in different
interactions with cell culture media components and cells.
Further investigations are required to analyze these differences,
and this should be the focus of future studies.
The reason for DNA damage is generally explained by the
accumulation of the particles around the nucleus where the
DNA content is high. To support this hypothesis, all three
types of cells were imaged after the incubation with particle D
using the fluorescence images. This particle was selected
because it caused the highest toxicity and the most significant
alteration on the cell cycle phases. The images in Figure 11
showed that the nanoparticles entered the nucleus of all cell
types, which support the results obtained from cell cycle and
DNA damage experiments.19,52 In all three images, the cell
morphologies are similar to the morphology of the cells before
treatment (Figure S12) indicating no apoptotic behavior
because of the exposure to particles.
■ CONCLUSION
In this study, different PEG-coated AuNPs, obtained by
changing the AuNP core size and PEG coating concentrations,
were characterized in terms of cumulative size, surface charge,
PEG layer conformation, grafting density, and hydrodynamic
volume. In particular, the effects of PEG grafting density and
hydrodynamic volume on stability (protein adsorption), cellular
uptake, toxicity, cell cycle, apoptosis, and DNA damage were
evaluated. The results indicated that the adsorbed PEG
molecules achieved brush conformation on all nanoparticles;
however, the PEG grafting densities and hydrodynamic
volumes on the particles were different depending on the
core size and PEG concentration. PEG hydrodynamic volume,
steric hindrance, and core size had control over protein
adsorption, stability, cellular uptake, and toxicity, whereas PEG
grafting density was found to be the major factor determining
the effect of particles on cell cycle and DNA damage. All of the
particles formulated, regardless of their surface properties, led
to significant cell cycle alteration and DNA damage especially
against CaCo2 and PC3 cancer cells at certain doses without
causing any apoptotic behavior. However, in healthy 3T3 cells,
the particles possessing certain PEG grafting density values
(∼0.65 chains/nm2) did not cause any significant cell cycle
alteration, apoptosis, or DNA damage, whereas below or above
this value severe damage was observed. Considering the fact
that the renal clearance of gold particles is possible if their sizes
are smaller than 10 nm, it can be suggested that particles
prepared from the 5 nm AuNP core size with ∼0.65 chains/
nm2 PEG grafting density could be a good candidate for further
in vivo investigations. Overall, these results suggested that
depending on the cell type, it is possible to adjust PEG grafting
density and hydrodynamic volume at a certain value in which
particles are not only capable of keeping their stability and
providing efficient cellular uptake but also not causing cell cycle
arrest, apoptosis, or DNA damage.
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